1. Home
  2. CUTR vs POAI Comparison

CUTR vs POAI Comparison

Compare CUTR & POAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CUTR
  • POAI
  • Stock Information
  • Founded
  • CUTR 1988
  • POAI 2002
  • Country
  • CUTR United States
  • POAI United States
  • Employees
  • CUTR N/A
  • POAI N/A
  • Industry
  • CUTR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • POAI Industrial Specialties
  • Sector
  • CUTR Health Care
  • POAI Health Care
  • Exchange
  • CUTR Nasdaq
  • POAI Nasdaq
  • Market Cap
  • CUTR 9.2M
  • POAI 8.5M
  • IPO Year
  • CUTR 2004
  • POAI N/A
  • Fundamental
  • Price
  • CUTR $0.47
  • POAI $1.48
  • Analyst Decision
  • CUTR Hold
  • POAI Hold
  • Analyst Count
  • CUTR 3
  • POAI 1
  • Target Price
  • CUTR $3.00
  • POAI N/A
  • AVG Volume (30 Days)
  • CUTR 1.6M
  • POAI 3.7M
  • Earning Date
  • CUTR 03-20-2025
  • POAI 11-12-2024
  • Dividend Yield
  • CUTR N/A
  • POAI N/A
  • EPS Growth
  • CUTR N/A
  • POAI N/A
  • EPS
  • CUTR N/A
  • POAI N/A
  • Revenue
  • CUTR $155,210,000.00
  • POAI $1,484,223.00
  • Revenue This Year
  • CUTR N/A
  • POAI N/A
  • Revenue Next Year
  • CUTR $4.61
  • POAI $569.48
  • P/E Ratio
  • CUTR N/A
  • POAI N/A
  • Revenue Growth
  • CUTR N/A
  • POAI N/A
  • 52 Week Low
  • CUTR $0.28
  • POAI $0.55
  • 52 Week High
  • CUTR $3.18
  • POAI $3.76
  • Technical
  • Relative Strength Index (RSI)
  • CUTR 54.47
  • POAI 61.56
  • Support Level
  • CUTR $0.36
  • POAI $1.16
  • Resistance Level
  • CUTR $0.50
  • POAI $1.42
  • Average True Range (ATR)
  • CUTR 0.11
  • POAI 0.43
  • MACD
  • CUTR 0.01
  • POAI 0.00
  • Stochastic Oscillator
  • CUTR 20.16
  • POAI 31.00

About CUTR Cutera Inc.

Cutera Inc is a medical device company that specializes in designing, developing, manufacturing, marketing, and servicing laser and other energy-based aesthetics systems for practitioners internationally. Its products include enlighten, excel HR, excel V, Xeo and Trusculpt 3D among others. The company markets and sells its products under the trademarks such as Cutera, Acutip, Coolglide, Enlighten, Excel HR, Excel V, Genesis plus, Pico-genesis, Titan, Trusculpt, and Xeo among others. It derives the majority of its revenue from the United States segment. Its products enable medical practitioners to perform safe procedures including treatment for acne, body contouring, skin resurfacing and revitalization, hair and tattoo removal, removal of benign pigmented lesions, and vascular conditions.

About POAI Predictive Oncology Inc.

Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.

Share on Social Networks: